Joost Sluijter

Professor Cellular and Translational Cardiology @UMCUtrecht @RMUtrecht @CirculatHealth

[Benedetta Izzi @BenedettaIzzi]

@ELaraPezzi #cardiotwitter #ISCTR @pjrbarton @JSluijter @SolovevaAnzhela @GuopingLi2 @roddywalsh @LauraIop_UNIPD @SmartNicola @SpringerNature

[Benedetta Izzi @BenedettaIzzi]

@ELaraPezzi
#ISCTR @pjrbarton

@JSluijter

@SolovevaAnzhela

@GuopingLi2

@roddywalsh

@LauraIop_UNIPD

@SmartNicola

@SpringerNature

[Benedetta Izzi @BenedettaIzzi]

💔 #HFpEF is more than a heart issue—it’s a multisystem syndrome driven by inflammation, metabolism & organ crosstalk. Current drugs help some, but precision, multi-organ therapies are the future. Read that in #JCTR #CardioTwitter 👉https://t.co/VDMbfTcMFI @ELaraPezzi #ISCTR

[Benedetta Izzi @BenedettaIzzi]

@pjrbarton
@JSluijter
@SolovevaAnzhela
@GuopingLi2
@roddywalsh
@LauraIop_UNIPD
@SmartNicola
@SpringerNature

[Circ: Heart Failure @CircHF]

Unraveling the Pathophysiological Mechanisms of Phospholamban R14del Cardiomyopathy: A Comprehensive Overview @jsluijter #AHAJournals https://t.co/HPyYwuWuRS

[Oren Caspi 🎗️ @MDCaspi]

✨ Wondering where the next-gen #Cardiovascular therapies will come from?

💡 Proud to be part of the CARE (Cardiovascular Regenerative & Reparative Medicine) Nucleus, ESC Working Group!
@ESCWGCAREChair #ESCCongress
Join Here...
https://t.co/jesDY4z0zi

[Benedetta Izzi @BenedettaIzzi]

Improving streamlined remote monitoring in #HF with #HeartLogic: workflow redesign led to a decrease in HeartLogic enablement time and reduction in delayed data transmissions 👉#JCTR https://t.co/J35NcWD7GD @ELaraPezzi #ISCTR

[Nazma Ilahibaks @nazmailahibaks]

Extracellular vesicles can transform regenerative medicine. Here's why they could enable cardiac repair.

Read our recent editorial in Nanomedicine↓

https://t.co/3opl4KXQer

@CircHealth_umcu @JSluijter

[Circ: Heart Failure @CircHF]

Living human myocardial slices hold translational potential for predicting the reversibility of chemotherapy-induced cardiotoxicity #AHAJournals @jsluijter @jpvantintelen @UMCUtrecht @CirculatHealth @Joost_sluijter https://t.co/3ZgcEY8ncf

[Benedetta Izzi @BenedettaIzzi]

#magnesium depletion score #MDS is a novel #CVD risk factor, but is it also and specifically for #PAD? in #JCTR a population study identifies an increased risk for the elderly. Read the data from the National Health and Nutrition Examination Survey 👉https://t.co/38Uptuu5jg

[Benedetta Izzi @BenedettaIzzi]

Transplanting cardiac microtissues #CMTs with a triple immunosuppression protocol show better engraftment and longer survival in a #heartInjury model. A promising study just published in #JCTR by @JSluijter's group! https://t.co/w5Mlyxogyp @ELaraPezzi #ISCTR

[Joost Sluijter @JSluijter]

Human cardiac microtissues have improved engraftment and survival in the heart upon injection vs single cells! A great collaborative achievement and real pleasure to work with this team. Enjoy reading!
@UMCU_Intl https://t.co/gCqJ6wIUVS

https://t.co/0TJGSfpcAJ

[Joost Sluijter @JSluijter]

Interested in the role of Extracellular Vesicles in the cardiovascular system?
See our recent work to provide a stepping stone towards more understanding!

https://t.co/D8gTBAhOcu

[Benedetta Izzi @BenedettaIzzi]

🫀 New insights alert! 🚨 Discover how emerging #PostTranslationalModifications are reshaping our understanding of #CVD! Read the cutting-edge science behind it in this #JCTR review: https://t.co/qM7GRzZLNC #ISCTR @ELaraPezzi

[Benedetta Izzi @BenedettaIzzi]

It's this time of the year! Announcing the best 2024 #JCTR paper: Gut Microbiota as Predictive Biomarker for Chronic Heart Failure in Patients with Different Nutritional Risk by Yang et al. https://t.co/uP2NC6Dyw0 Congratulations to the Authors!

[Benedetta Izzi @BenedettaIzzi]

The JCTR Editorial board is also proud to announce the 6 most commended papers of 2024: https://t.co/fIrGUEflpP #ISCTR @ELaraPezzi @pjrbarton @JSluijter @SolovevaAnzhela @GuopingLi2 @roddywalsh @LauraIop_UNIPD @SmartNicola @SpringerNature👇👇

[Benedetta Izzi @BenedettaIzzi]

What if you could permanently regulate your #LDL cholesterol levels? Read on #JCTR the promising application of #CRISPRCas9 editing strategy to help prevent atherosclerosis and CVD 👉https://t.co/bG8Vy2xEyL #ISCTR @ELaraPezzi

[Nazma Ilahibaks @nazmailahibaks]

Are you interested in extracellular vesicles and CRISPR gene editing? Check out the post-doc position on EV-mediated CRISPR delivery for treating a rare cardiomyopathy @UMCUtrecht

Don’t miss your chance to apply by January 12th!

https://t.co/aC5KoBaTzM

@ISEV_Journals @NLSEV_

[Joost Sluijter @JSluijter]

@MaxGnecchi We should find an occasion Max!! 🍷
Enjoy the holidays!!